Back
Collegium Pharmaceutical 10K Form
Buy
70
COLL
Collegium Pharmaceutical
Last Price:
38.93
Seasonality Move:
31.73%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-07 | 10Q | COLL/Collegium Pharmaceutical Quarterly |
| 2023-08-03 | 10Q | COLL/Collegium Pharmaceutical Quarterly |
| 2023-05-04 | 10Q | COLL/Collegium Pharmaceutical Quarterly |
| 2022-11-03 | 10Q | COLL/Collegium Pharmaceutical Quarterly |
| 2022-08-04 | 10Q | COLL/Collegium Pharmaceutical Quarterly |
| 2022-05-10 | 10Q | COLL/Collegium Pharmaceutical Quarterly |
Receive COLL News And Ratings
See the #1 stock for the next 7 days that we like better than COLL
COLL Financial Statistics
Sales & Book Value
| Annual Sales: | $566.77M |
|---|---|
| Cash Flow: | $67.13M |
| Price / Cash Flow: | 6.55 |
| Annual Sales: | $6.70 |
| Price / Book: | 5.79 |
Profitability
| EPS (TTM): | 2.59000 |
|---|---|
| Net Income (TTM): | $99.89M |
| Gross Margin: | $326.17M |
| Return on Equity: | 49.26% |
| Return on Assets: | 8.76% |
Collegium Pharmaceutical Earnings Forecast
Key Collegium Pharmaceutical Financial Ratios
- The Gross Profit Margin over the past 10 years for COLL is 57.55%.
- The Selling, General & Administrative Expenses for COLL have been equal to 28.09% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 173.06% of Operating Income.
- The Net Earning history of COLL is 8.50% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 7 years.
Collegium Pharmaceutical Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | COLL |
| CUSIP: | 19459J |
| Website: | collegiumpharma.com |
Debt
| Debt-to-Equity Ratio: | 2.55 |
|---|---|
| Current Ratio: | 1.11 |
| Quick Ratio: | 0.99 |
Price-to-Earnings
| Trailing P/E Ratio: | 30.19 |
|---|---|
| Forward P/E Ratio: | 5.74 |
COLL Technical Analysis vs Fundamental Analysis
Buy
70
Collegium Pharmaceutical (COLL)
is a Buy
Is Collegium Pharmaceutical a Buy or a Sell?
-
Collegium Pharmaceutical stock is rated a Buy
The current Collegium Pharmaceutical [COLL] share price is $38.94. The Score for COLL is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.